High cell surface death receptor expression determines type I versus type II signaling
about
Membrane trafficking of death receptors: implications on signallingHistone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cellsPoly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.CD95 is part of a let-7/p53/miR-34 regulatory networkEnhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and BakDeath ligand concentration and the membrane proximal signaling module regulate the type 1/type 2 choice in apoptotic death signaling.Monte carlo study elucidates the type 1/type 2 choice in apoptotic death signaling in healthy and cancer cells.Mouse Lung Fibroblast Resistance to Fas-Mediated Apoptosis Is Dependent on the Baculoviral Inhibitor of Apoptosis Protein 4 and the Cellular FLICE-Inhibitory Protein.Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cellsDifferential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cellsmiRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.
P2860
Q26852802-D0222FD8-51E4-4E09-879D-5CCD03C2CE1EQ33808800-F0A4F577-3348-40E3-999A-FF18EB918187Q33947014-759567B9-8047-4D82-AAC4-AFFF65612020Q34482626-A33559B0-D61C-48BA-9C61-DD706A701468Q35763155-7D892E52-4A22-4190-B8E5-29CF4F11B802Q36965860-75E00B2C-7DE6-4B39-8F83-3B645C51B0C6Q36967364-913D78A8-8114-4A7B-A8E3-45BBBD311B0AQ37095358-CCA56243-4E3C-4CA0-B8A2-07A84521B0DAQ37601161-BCF4A04C-9E32-424F-826B-CB9C1BECC0E5Q37679250-649221EB-AF0A-44A8-9C9E-287D29EF12A9Q37697394-A4D826C5-652F-414A-AB65-ED831BB96019Q38445385-039409E9-E383-4AF8-AB31-BC51BB4472BDQ39011040-D8DA0092-C22F-4682-B2F4-95DD46063FF0Q43162081-6DB46BEC-4188-46D6-8B54-E30BC0FD5EFA
P2860
High cell surface death receptor expression determines type I versus type II signaling
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High cell surface death receptor expression determines type I versus type II signaling
@ast
High cell surface death receptor expression determines type I versus type II signaling
@en
type
label
High cell surface death receptor expression determines type I versus type II signaling
@ast
High cell surface death receptor expression determines type I versus type II signaling
@en
prefLabel
High cell surface death receptor expression determines type I versus type II signaling
@ast
High cell surface death receptor expression determines type I versus type II signaling
@en
P2093
P2860
P50
P356
P1476
High cell surface death receptor expression determines type I versus type II signaling
@en
P2093
Alexander Koenig
Daniel D Billadeau
Jin-San Zhang
Kevin L Peterson
Paula Schneider
Steve Bronk
Sun-Hee Lee
Xue Wei Meng
P2860
P304
35823-35833
P356
10.1074/JBC.M111.240432
P407
P577
2011-08-24T00:00:00Z